Related Experiment Video
Updated: Jun 23, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Thyroid cancer in young adults.
Anita K Ying1, Winston Huh, Sarah Bottomley
1Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Seminars in Oncology
|May 23, 2009
Summary
Thyroid cancer incidence is increasing in young adults. Optimal care for differentiated thyroid carcinoma and medullary thyroid carcinoma involves multidisciplinary coordination, utilizing ultrasound-guided fine needle aspiration and tailored therapies for improved outcomes.
Area of Science:
- Oncology
- Endocrinology
Background:
- Rising incidence of thyroid cancer in young adults.
- Differentiated thyroid carcinoma (DTC) and medullary thyroid carcinoma (MTC) are common subtypes with distinct characteristics.
- Papillary thyroid carcinoma (PTC) has an excellent prognosis.
Purpose of the Study:
- To outline the diagnostic and management strategies for thyroid cancer in young adults.
- To highlight the importance of a multidisciplinary approach in treating thyroid cancer.
- To discuss current and emerging therapeutic options.
Main Methods:
- Ultrasound (US)-guided fine needle aspiration (FNA) for initial nodule evaluation.
- Tumor histology, radiographic findings, and clinical presentation guide management.
- Radioactive iodine (RAI) therapy for DTC recurrence reduction and survival improvement.
Main Results:
- US-guided FNA is the primary diagnostic tool for suspicious thyroid nodules.
- Histology and clinical factors dictate surgical management and adjuvant therapies.
- Emerging systemic therapies offer new options for advanced or radio-resistant cases.
Conclusions:
- Multidisciplinary care is optimal for young adult thyroid cancer patients.
- Tailored treatment strategies based on subtype and stage are crucial.
- Prognosis for PTC, the most common type, is generally excellent.
Related Concept Videos
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...